These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4635959)

  • 41. [Treatment with calcitonin].
    Falch J
    Tidsskr Nor Laegeforen; 1979 Aug; 99(22):1007-8. PubMed ID: 483291
    [No Abstract]   [Full Text] [Related]  

  • 42. Kinetic and metabolic investigations in Paget's disease of bone, assessment of human synthetic calcitonin therapy.
    Reiner M; Woodhouse NJ; Kalu DN; Foster GV; Galante L; Joplin GF; MacIntyre I
    Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:136. PubMed ID: 5288785
    [No Abstract]   [Full Text] [Related]  

  • 43. [Hyperparathyroidism].
    Sone T
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():229-32. PubMed ID: 16279637
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of hyperparathyroid crisis].
    Jorgensen H; Frey H; Sander S; Saevareid L
    Tidsskr Nor Laegeforen; 1977 Feb; 97(6):279-83. PubMed ID: 139706
    [No Abstract]   [Full Text] [Related]  

  • 45. Calcitonin.
    Potts JT; Niall HD; Deftos LJ
    Curr Top Exp Endocrinol; 1971; 1():151-73. PubMed ID: 4949942
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
    Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
    [No Abstract]   [Full Text] [Related]  

  • 47. [Calcitonin in the treatment of Paget's bone disease].
    Pacovský V; Stĕpán J; Ston J; Formánková J
    Cas Lek Cesk; 1980; 119(11):329-33. PubMed ID: 7397720
    [No Abstract]   [Full Text] [Related]  

  • 48. [Parathyroid hormone, calcitonin and bone diseases].
    Ziegler R
    Dtsch Med J; 1971 Mar; 22(6):160-3. PubMed ID: 4929556
    [No Abstract]   [Full Text] [Related]  

  • 49. [Calcitonin].
    Taurand P; Taurand S
    Soins; 1991 Nov; (554):I-II. PubMed ID: 1767292
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of Paget's disease with calcitonin.
    DeRose J; Avramides A; Baker RK; Wallach S
    Semin Drug Treat; 1972; 2(1):51-5. PubMed ID: 5065517
    [No Abstract]   [Full Text] [Related]  

  • 51. [Problems in calcitonin research].
    Haas HG; Dambacher MA; Guncaga J; Lauffenburger T; Lentner C
    Klin Wochenschr; 1972 Jan; 50(1):2-11. PubMed ID: 4550931
    [No Abstract]   [Full Text] [Related]  

  • 52. [Chronopharmacological effect of porcine calcitonin in Paget's disease of the bone].
    Tarquini B; Ciapini A; Benvenuti M; Moretti R; Cherici R; Comparini T; Neri B
    Clin Ter; 1980 Sep; 94(6):659-70. PubMed ID: 7460500
    [No Abstract]   [Full Text] [Related]  

  • 53. [Paget's disease. Acute attacks treated with calcitonin. Thermographic study].
    Camus JP; Tricoire J; Mariel L; Prier A
    Nouv Presse Med; 1973 Oct; 2(38):2517-9. PubMed ID: 4763456
    [No Abstract]   [Full Text] [Related]  

  • 54. Combined therapy with ascorbic acid and calcitonin for the relief of bone pain in Paget's disease.
    Smethurst M; Basu TK; Gillett MB; Donaldson D; Jordan SJ; Williams DC; Hicklin JA
    Acta Vitaminol Enzymol; 1981; 3(1):8-11. PubMed ID: 7293873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Paget's disease of bone.
    Haddad JG
    Curr Ther Endocrinol Metab; 1994; 5():525-7. PubMed ID: 7704787
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical applications of calcitonin.
    Can Med Assoc J; 1971 Aug; 105(3):238-9. PubMed ID: 5563336
    [No Abstract]   [Full Text] [Related]  

  • 57. [Influence of porcine calcitonin in 3 healthy patients and in a female patient with Paget's disease].
    Aznar Reig A; Zamora Madaria E; Herrera Justiniano E; Rubio Rubio JM; Gómez San Millán M; Merchante C
    Rev Iber Endocrinol; 1971; 18(107):419-42. PubMed ID: 5133441
    [No Abstract]   [Full Text] [Related]  

  • 58. Calcitonin.
    Sewell KL
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):56S-62S. PubMed ID: 9273940
    [No Abstract]   [Full Text] [Related]  

  • 59. [Letter: Treatment of hypercalcemic hyperparathyroidism].
    Hesch RD
    Med Klin; 1974 Apr; 69(16):714-5. PubMed ID: 4837403
    [No Abstract]   [Full Text] [Related]  

  • 60. [Calcitonin--physiology and possibilities for therapeutic treatment (author's transl)].
    Merceron RE
    Munch Med Wochenschr; 1973 Sep; 115(38):1589-94. PubMed ID: 4800868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.